期刊文献+

羟基喜树碱pH敏感阳离子纳米脂质体的制备 被引量:3

Preparation of Hydroxycamptothecin pH-Sensitive Cationic Nanoliposomes
原文传递
导出
摘要 目的以羟基喜树碱作为模型药物研究pH敏感阳离子纳米脂质体用于包载抗癌药物的制备工艺。方法采用薄膜分散法制备羟基喜树碱阳离子脂质体;用羧甲基壳聚糖物理修饰阳离子脂质体;用葡聚糖凝胶柱色谱法分离游离药物;用紫外分光光度法测定包封率;用单一因素考察法优选处方;经高压乳匀得到纳米脂质体(粒径小于100nm);用激光粒度分析仪测定Zeta电位、粒径大小。结果最佳处方制备的药物平均包封率为(78.5±0.9)%(n=3);包衣纳米脂质体的Zeta电位为-31.3mV,平均粒径为96nm。结论使用本方法制备pH敏感阳离子纳米脂质体工艺简单,有望获得高靶向性的抗癌药物传递系统。 OBJECTIVE To prepare pH-sensitive cationic nanoliposomes with hydroxycamptothecin (HCPT) as model drug. METHODS The cationic liposomes were prepared by film dispersion method. Tbe encapsulation efficiency was determined by Ultra Violet Detector. HCPT loaded within liposomes was estimated alter removing unentrapped HCPT by Sephadex - G50 chromatographic column. Carboxymethyl ehitosan was used to coat the cationic liposomes , then the liposoines were extruded through high pressure homogenizer. Zeta sizer was used to determine the Zeta potential and average size of the HCPT liposomes. RESULTS The size of liposomes was around 96 nm and drug encapsulation efficiency was 78.5%. CONCLUSION The preparation of this stable, long circu- lating pH-sensitive cationic HCPT containing nanoliposomes are easy to prepare and the drug concentration of pH-sensitive cationic nanoliposomes in tumor cells was remarkably higher than that of free drug.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第6期450-453,共4页 Chinese Pharmaceutical Journal
基金 国家973计划项目(2009CB930301)
关键词 PH敏感 阳离子 长循环 纳米脂质体 pH-sensitive cationic long-circulating nanoliposome
  • 相关文献

参考文献2

二级参考文献33

  • 1Joan D. Webster-Gandya, Chris Howa, K et al.Palmar - plantar erythrodysesthesia (PPE): A fiterature review with commentary on experience in a cancer centre[J].European Journal of Oncology Nursing (2007) 11,238-246 被引量:1
  • 2Jacobi U,Waibler E, Schuhe P, et al. Release of doxorubicin in sweat:first step to induce the palmar-plantar erythrodysesthesia syndrome?[J].The European Society for Medical Oncology,2005, 16(7):1210-1211 被引量:1
  • 3Mary E, Gordinier, Don S, et al.Elevated body mass index does not increase the risk of palmar - plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin[J], Gynecologic Oncology,2006,106:72 - 74 被引量:1
  • 4Lin E, Morris js, Ayers GD.Effect of celecoxib on capecitabine-induced hand-- foot syndrome and antitumor activity[J].Oncology(Williston Park), 2002, 16(12 SupplNo 14):31- 37 被引量:1
  • 5Samer Abushullaih, M.D,Everardo D, et al. Incidence and Severity of Hand-Foot.Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-institution Experience.Cancer Investigation[J].002, 20(1), 3-10 被引量:1
  • 6Yvonne Lassere, Paulo Hoff.Management of hand-foot syndrome in patients treated with capecitabine (Xelodas). European Journal of Oncology Nursing[J]. 2004,8,31 - 40 被引量:1
  • 7Ismail Oguz Kara, Berksoy Sahin, M. Erkisi. Palmar - plantar erythrodysesthesia due to docetaxel - capecitabine therapy is treated with vitamin E without dose reduction[J]. The Breast (2006) 15, 414 - 424 被引量:1
  • 8Roger von Moos, Beat J.K, Thuerlimann, et al.Pegylated liposomal doxorubicin-associated hand - foot syndrome: Recommendations of an international panel of experts[J].European Journal Of Cancer.2008, 44(6):781-790 被引量:1
  • 9Ibrahim NK, Valero V, Theriault RL et al. Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer[J].American Journal of Clinical Oncology 2000, 23 (2): 117-121. 被引量:1
  • 10Laack E, Mende T, Knuffmann C, et al.Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine[J]. Annals of Oncology. December 2001, 12(12), 1761-1763 被引量:1

共引文献34

同被引文献55

  • 1林友文,苏燕评,蒋智清.羧甲基壳聚糖水凝胶的pH敏感性及体外释药性能[J].福建医科大学学报,2005,39(3):331-334. 被引量:14
  • 2帅武平,张幸国,陈金亮,何彩丽,梁文权,高建青.壳聚糖修饰脂质体的制备和性质研究[J].中国药学杂志,2007,42(15):1159-1163. 被引量:13
  • 3GERWECK L W,VIJAYAPPA S,KOZIN S.Tumor pH controlsthe in vivo efficacy of weak acid and base chemotherapeutics[J].Mol Cancer Ther,2006,5(5):1275-1279. 被引量:1
  • 4Kamath K R, Park K. Biodegradable hydrogels in drug delivery [J]. Adv Drug Deliv Rev, 1993, 11(1/2):59-84. 被引量:1
  • 5Park H, Park K, Shalaby W S W. Biodegradable Hydrogels for Drug Delivery [M]. Boca Raton: CRC Press, 1993: 120-125. 被引量:1
  • 6Firestone B A, Siegel R A. Kinetics and mechanisms of water sorption in hydrophobic, ionizable copolymer gels [J]. JAppl Polym Sci, 1991, 43(5): 901-914. 被引量:1
  • 7Falamarzian M, Varshosaz J. The effect of structural changes on swelling kinetics of polybasic /hydrophobic pH sensitive hydrogels [J]. Drug Dev Ind Pharm, 1998, 24(7): 667-669. 被引量:1
  • 8Kou J H, Amidon G L, Lee P I. pH-dependent swelling and solute diffusion characteristics of poly(hydroxyethyl methacrylate-co-methacrylic acid) hydrogels [J]. Pharm Res, 1988, 5(9): 592-597. 被引量:1
  • 9Brannon-Peppas L, Peppas N A. Dynamic and equilibrium swelling behaviour of pH-sensitive hydrogels containing 2-hydroxyethyl methacrylate [J]. Biomaterials, 1990, 11(9): 635-644. 被引量:1
  • 10Khare A R, Peppas N A. Release behavior of bioactive agents from pH-sensitive hydrogels [J]. J Biomater Sci: Polym Ed, 1993, 4(3): 275-289. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部